Eversept Partners’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.51M | Buy |
414,430
+133,479
| +48% | +$2.42M | 0.69% | 34 |
|
|
2025
Q1 | $5.75M | Buy |
280,951
+5,589
| +2% | +$114K | 0.58% | 32 |
|
|
2024
Q4 | $7.08M | Sell |
275,362
-31,995
| -10% | -$822K | 0.63% | 30 |
|
|
2024
Q3 | $5.1M | Sell |
307,357
-22,533
| -7% | -$374K | 0.35% | 35 |
|
|
2024
Q2 | $6.34M | Sell |
329,890
-24,075
| -7% | -$462K | 0.43% | 37 |
|
|
2024
Q1 | $8.37M | Sell |
353,965
-20,439
| -5% | -$483K | 0.56% | 30 |
|
|
2023
Q4 | $4.18M | Sell |
374,404
-286,214
| -43% | -$3.2M | 0.37% | 40 |
|
|
2023
Q3 | $6.11M | Sell |
660,618
-31,751
| -5% | -$294K | 0.52% | 30 |
|
|
2023
Q2 | $8.23M | Buy |
692,369
+646,513
| +1,410% | +$7.69M | 0.69% | 29 |
|
|
2023
Q1 | $608K | Buy |
+45,856
| New | +$608K | 0.04% | 57 |
|